# AbbVie Inc. (ABBV): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/abbv for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Drug Manufacturers - General
- Exchange: NYSE · Trading currency: USD

AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VE...

## Quote & Key Metrics

As of 2026-10-22:

| Metric | Value |
|---|---|
| Price | $284.89 USD |
| Market Cap | $503.43B |
| P/E (TTM) | 26.21 |
| EPS (TTM) | $10.87 |
| 52-Week Range | $190.75 – $291.40 |
| Dividend Yield (TTM) | 2.43% |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | 2.43% |
| Annual Dividend (TTM) | $6.92 /share |
| Annual Dividend (Forward) | $6.92 /share |
| Frequency | Quarterly |
| Consecutive Growth Streak | 13 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | 5.5% / 5.3% / 5.9% / 11.7% |
| Payout Ratio (EPS, TTM) | 189.9% |
| Payout Ratio (FCF, TTM) | 65.5% |
| Payout Ratio (EPS, forward dividend) | 195.0% |
| Payout Ratio (FCF, forward dividend) | 67.3% |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2026-10-15 | $1.7300 | 2026-11-16 |
| 2026-07-15 | $1.7300 | 2026-08-14 |
| 2026-04-15 | $1.7300 | 2026-05-15 |
| 2026-01-16 | $1.7300 | 2026-02-17 |
| 2025-10-15 | $1.6400 | 2025-11-14 |
| 2025-07-15 | $1.6400 | 2025-08-15 |
| 2025-04-15 | $1.6400 | 2025-05-15 |
| 2025-01-15 | $1.6400 | 2025-02-14 |
| 2024-10-15 | $1.5500 | 2024-11-15 |
| 2024-07-15 | $1.5500 | 2024-08-15 |
| 2024-04-12 | $1.5500 | 2024-05-15 |
| 2024-01-12 | $1.5500 | 2024-02-15 |

Full history: https://www.dividenddata.com/stocks/abbv/dividend

## Frequently Asked Questions

### What does AbbVie Inc. do?

AbbVie Inc. (ABBV) operates in the Drug Manufacturers - General industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is ABBV's market cap?

AbbVie Inc. (ABBV) has a market capitalization of approximately $503.43 billion, as of October 22, 2026, based on the most recent share price and shares outstanding.

### Does ABBV pay a dividend?

Yes, AbbVie Inc. (ABBV) pays a dividend quarterly, with a trailing-twelve-month yield of 2.43%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

### How often does ABBV pay dividends?

AbbVie Inc. pays dividends quarterly. The forward annual rate is $6.92 per share at the current declared cadence. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is ABBV's payout ratio?

AbbVie Inc.'s payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

### Is ABBV a Dividend Aristocrat?

Yes, AbbVie Inc. (ABBV) is an S&P 500 Dividend Aristocrat, meaning it has raised its dividend for at least 25 consecutive years. Its full dividend history and growth rates are on this page.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/abbv
- Dividend history & safety: https://www.dividenddata.com/stocks/abbv/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/abbv/earnings
- Financial statements: https://www.dividenddata.com/stocks/abbv/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/abbv/valuation
- Peer comparison: https://www.dividenddata.com/stocks/abbv/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.